Ocular Pharmacology and Emerging Therapies

Innovations in ocular pharmacology are expanding therapeutic options for a wide range of eye diseases. This session explores emerging medications, drug-delivery systems, biologic therapies, sustained-release treatments, and targeted approaches to ocular disease management. Discussions will address treatments for retinal disorders, glaucoma, ocular inflammation, corneal diseases, and other conditions. Novel delivery technologies may improve drug penetration, treatment duration, adherence, and patient convenience. Personalized treatment approaches and precision therapeutics will also be considered. Researchers will discuss clinical development, treatment safety, efficacy, and challenges associated with translating new therapies into routine practice. The role of biotechnology and pharmaceutical innovation in developing next-generation ophthalmic treatments will receive attention.

 

    Related Conference of Ocular Pharmacology and Emerging Therapies

    September 14-15, 2026

    40th European Ophthalmology Congress

    Rome, Italy
    September 14-15, 2026

    7th World Congress on Ophthalmology and Vision Science

    Rome, Italy
    September 14-15, 2026

    6th European Congress on Laser, Optics and Photonics

    Barcelona, Spain
    September 21-22, 2026

    21st International Conference on Ophthalmology and Vision Science

    Amsterdam, Netherlands
    October 05-06, 2026

    26th Global Ophthalmologists Annual Meeting

    Rome, Italy
    October 15-16, 2026

    8th International Conference on Optometry

    Paris, France
    December 03-04, 2026

    9th International Eye and Vision Congress

    Madrid, Spain
    April 28-29, 2027

    4th International Conference on Ophthalmology

    Paris, France

    Ocular Pharmacology and Emerging Therapies Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in